vx-745 has been researched along with arry-371797 in 1 studies
| Studies (vx-745) | Trials (vx-745) | Recent Studies (post-2010) (vx-745) | Studies (arry-371797) | Trials (arry-371797) | Recent Studies (post-2010) (arry-371797) |
|---|---|---|---|---|---|
| 58 | 1 | 35 | 8 | 1 | 6 |
| Protein | Taxonomy | vx-745 (IC50) | arry-371797 (IC50) |
|---|---|---|---|
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.0045 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, DM; Kuglstatter, A; Lou, Y; Soth, MJ | 1 |
1 other study(ies) available for vx-745 and arry-371797
| Article | Year |
|---|---|
Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders.
Topics: Arthritis, Rheumatoid; Chronic Disease; Clinical Trials, Phase II as Topic; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Indoles; Inflammatory Bowel Diseases; Models, Molecular; Molecular Structure; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; Protein Binding; Psoriasis; Pyridones; Pyrimidines; Treatment Outcome | 2010 |